HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limitations to survival for infants with hypoplastic left heart syndrome before and after transplant: the Loma Linda experience.

Abstract
Untreated, hypoplastic left heart syndrome is a lethal cardiac defect. Heart transplant has become an accepted therapeutic option for this condition. However, significant limitations to survival remain for infants with this condition who are referred for heart transplantation. Attention to the prevention, early detection, and management of common problems occurring at each stage of the transplantation process is important for improving survival rates. This study retrospectively reviewed the cases of 195 infants with hypoplastic left heart syndrome registered for heart transplantation at Loma Linda University Medical Center between November 1985 and July 1996 to determine causes of death. During the waiting period, progressive cardiac failure and complications from interventional procedures were the leading causes. In the early postoperative period, technical issues and acute graft failure were most important, whereas late deaths (more than 30 days after transplant) were most often related to rejection and posttransplant coronary artery disease.
AuthorsJ K Johnston, R E Chinnock, C W Zuppan, A J Razzouk, S R Gundry, L L Bailey
JournalJournal of transplant coordination : official publication of the North American Transplant Coordinators Organization (NATCO) (J Transpl Coord) Vol. 7 Issue 4 Pg. 180-4; quiz 185-6 (Dec 1997) ISSN: 0905-9199 [Print] United States
PMID9510731 (Publication Type: Journal Article)
Topics
  • California
  • Cause of Death
  • Heart Transplantation (mortality)
  • Humans
  • Hypoplastic Left Heart Syndrome (mortality, surgery)
  • Infant
  • Infant, Newborn
  • Registries
  • Retrospective Studies
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: